{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-002246","form_type":"8-K","ticker":"CGC","cik":"0001737927","company_name":"Canopy Growth Corp","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.356846+00:00","generated_at":"2026-06-19T20:38:05.531377+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Canopy Growth Q3 net revenue down 28% to $101M; net loss $267M; announces major restructuring","bullets":["Net revenue $101.2M (-28% YoY), net loss $266.7M (-$151M YoY), adjusted EBITDA loss $87.5M.","Announces Canadian business transformation to asset-light: exit flower cultivation in Smiths Falls, close 1 Hershey Drive facility.","Headcount reduction ~60% (800 positions, 40% immediate); cost reduction target $140-160M additional, total $240-310M.","Pre-tax restructuring charges $425-525M ($25-40M cash); reaffirms positive Adjusted EBITDA in FY2024 (excl. BioSteel).","Cash $789M (down from $1,372M); gross debt $1,206M (down from $1,501M)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-002246","json":"https://secwatch.observer/filing/0000950170-23-002246.json","markdown":"https://secwatch.observer/filing/0000950170-23-002246.md","text":"https://secwatch.observer/filing/0000950170-23-002246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737927/000095017023002246/0000950170-23-002246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737927/000095017023002246/cgc-20230209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T20:38:05.531377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e7de768171fc553a43e1515be4b55e7b557aa56c","claim":"Canopy Growth Corp reported third quarter ended December 31, 2022 results: revenue $101 million, net income $267 million. Guidance reaffirmed.","evidence_excerpt":"\"Non-GAAP Measures\". 2 Adjusted EBITDA is a non-GAAP measure. See \"Non-GAAP Measures\". 3 Free cash flow is a non-GAAP measure. See \"Non-GAAP Measures\". Revenues: Net revenue of $101 million in Q3 FY2023 declined 28% versus Q3 FY2022. The decrease is primarily attributable to increased competition in the Canadian adult-use cannabis market, the divestiture of C3","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737927/000095017023002246/0000950170-23-002246-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended December 31, 2022"},{"label":"Revenue","value":"$101 million"},{"label":"Net income","value":"$267 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}